Skip to main content
OpenTrials
Completed

NCT Number: NCT05529381

Anxiety and Depressive Symptoms in Placenta Previa / Accreta

placenta previa is an obstetric complication which is associated with depression and anxiety.

As little is known about the emotional reaction to the diagnosis of placenta previa/accrete, a study is badly needed to estimate the magnitude of this problem and its effects on the mother

Completed

Looking for future studies?

Notify Me

Key information

About this study

Placenta previa is an obstetric complication with a prevalence of 5.2 per 1000 pregnancies. placenta previa is associated with maternal morbidity and mortality. The delivery carries a risk of bleeding, emergency hysterectomy, organ damage and even death. During admission, counselling is done for the possible need for delivery at any time and the need for life saving hysterectomy. hysterectomy is a tough and difficult choice for patients, and the subsequent emotional process is often associated with depression, severe and prolonged feelings of sadness, diminished interest in activities and in sexual intercourse. Similarly, severe adverse psychological outcomes, including post-traumatic stress disorders, have been reported as a result of traumatic birth events. Antenatal depression and anxiety occur in approximately 13% and up to 21.7% of women, respectively. Rates of antenatal depression among women hospitalized for obstetrical risk can be as high as 19%.

Research about the responses to a diagnosis of placenta previa is scarce. A study found increased anxiety score in women diagnosed with Placenta accreta spectrum. Other studies focussed on the post-trauma stress associated with hysterectomy versus uterine conservation.

As little is known about the emotional reaction to the diagnosis of placenta previa/accrete, a study is badly needed to estimate the magnitude of this problem and its effects on the mother.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patient diagnosed to have placenta previa or accrete
  • plan to deliver baby in Assiut women health hospital
  • willing and able to participate

Exclusion criteria

  • pre-existing psychological disorders
  • severe medical complications
  • severe obstetric complications
  • fetal abnormality

Treatment and study plan

Primary outcomes

  1. Assess stress, anxiety and depression symptoms in inpatients diagnosed to have placenta previa /accreta

    Time frame: 5 minutes

    Depression Anxiety Stress Scale-21

Secondary outcomes

  1. Effects of depressive and anxiety symptoms on women functioning and quality of life

    Time frame: 10 minutes

    SF-12 questionnaire

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Anxiety and Depressive Symptoms of Pregnant Women Diagnosed to Have Placenta Previa / Accreta

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
Sep 7, 2022
Registry last updated
Nov 8, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.